Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/253.01
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,4 diazines > Piperazines (i.e., fully hydrogenated 1,4-diazines) > Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding > The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms
Description: Subject matter wherein the additional hetero ring has exactly six members and consists of five carbon atoms and one nitrogen atom.

Sub-classes under this class:

Class Number Class Name Patents
514/253.12 Chalcogen bonded directly to ring carbon of the additional six-membered nitrogen containing hetero ring 185
514/253.11 Chalcogen hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding 256
514/253.09 Five-membered nitrogen hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding 518
514/253.13 Having -c(=x)-, wherein x is chalcogen, bonded directly to the additional six-membered nitrogen hetero ring 259
514/253.02 Polycyclo ring system having the additional six-membered nitrogen hetero ring as one of the cyclos 107

Patents under this class:
1 2 3 4 5 6 7 8 9 10 11 12 13 14

Patent Number Title Of Patent Date Issued
8710062 Piperazinedione compounds Apr. 29, 2014
8673910 Proteasome inhibitors for selectively inducing apoptosis in cancer cells Mar. 18, 2014
8669259 Heterocyclic amide compounds as protein kinase inhibitors Mar. 11, 2014
8664214 Small molecule potentiators of metabotropic glutamate receptors I Mar. 4, 2014
8664246 Substituted pyridines, and use thereof as GSK3 inhibitors Mar. 4, 2014
8664223 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase Mar. 4, 2014
8658207 Extended release tablet formulations of flibanserin and method for manufacturing the same Feb. 25, 2014
8653081 Certain chemical entities, compositions, and methods Feb. 18, 2014
8653080 Methods for screening and compounds that protect against amyloid diseases Feb. 18, 2014
8648067 Substituted phenoxypropylcycloamine derivatives as histamine-3 (H.sub.3) receptor ligands Feb. 11, 2014
8633196 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics Jan. 21, 2014
8623873 Substituted piperazines as CB1 antagonists Jan. 7, 2014
8598169 Biaryl compositions and methods for modulating a kinase cascade Dec. 3, 2013
8586589 Piperidine and piperazine phenyl sulfonamides as modulators of ion channels Nov. 19, 2013
8580792 Inhibitor compounds and cancer treatment methods Nov. 12, 2013
8580790 (Heterocycle/condensed piperidine)-(piperazinyl)-1-alkanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alkanone derivatives and use thereof as p75 inhibitors Nov. 12, 2013
8563582 3-aminocyclopentanecarboxamides as modulators of chemokine receptors Oct. 22, 2013
8557822 Carboxamide, sulfonamide and amine compounds and methods for using the same Oct. 15, 2013
8546401 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases Oct. 1, 2013
8545886 Extended release tablet formulations of flibanserin and method for manufacturing the same Oct. 1, 2013
8546396 N-(hetero)aryl, 2-(hetero)aryl--substituted acetamides for use as Wnt signaling modulators Oct. 1, 2013
8530469 Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 Sep. 10, 2013
8530465 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof Sep. 10, 2013
8530476 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase Sep. 10, 2013
8518948 Inhibitors of protein kinases Aug. 27, 2013
8518947 (Heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors Aug. 27, 2013
8513257 Ureas and their use in the treatment of heart failure Aug. 20, 2013
8507474 Anthelmintic agents and their use Aug. 13, 2013
8507493 Amide and amidine derivatives and uses thereof Aug. 13, 2013
8497273 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor Jul. 30, 2013
8492374 Azaazulene compounds Jul. 23, 2013
8486949 Use of azaperone for improving growth performance Jul. 16, 2013
8476280 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists Jul. 2, 2013
8476275 N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor Jul. 2, 2013
8476277 TRPV1 antagonists including dihydroxy substituent and uses thereof Jul. 2, 2013
8470827 3-aminocyclopentanecarboxamides as modulators of chemokine receptors Jun. 25, 2013
8466157 Proteasome inhibitors having chymotrypsin-like activity Jun. 18, 2013
8445495 Certain Chemical entities, compositions and methods May. 21, 2013
8431572 2-oxo-3-benzylbenzoxazol-2-one derivatives and related compounds as met kinase inhibitors for the treatment of tumours Apr. 30, 2013
8420643 Compounds and method for treatment of cancer Apr. 16, 2013
8410108 Certain chemical entities, compositions and methods Apr. 2, 2013
8399454 Azetidinyl diamides as monoacylglycerol lipase inhibitors Mar. 19, 2013
8383628 Pyridyl derivatives and their use as therapeutic agents Feb. 26, 2013
8372841 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme Feb. 12, 2013
8367675 Compounds and method for treatment of cancer Feb. 5, 2013
8343963 Sulfamoyl-phenyl-ureido compounds and their use as medicament Jan. 1, 2013
8343966 Organic compounds Jan. 1, 2013
8338428 Methods for administering aripiprazole Dec. 25, 2012
8338405 Therapeutic piperazines Dec. 25, 2012
8338426 Piperazinyl derivatives useful as modulators of the neuropeptide Y.sub.2 receptor Dec. 25, 2012

1 2 3 4 5 6 7 8 9 10 11 12 13 14

  Recently Added Patents
Radiation imaging device
Quaternary chalcogenide wafers
Methods and compositions for improving photodynamic therapy through administration of lipids
Compound containing a carbon or an oxygen isotope, preparation and use thereof, and composition comprising thereof
High sensitivity stress sensor based on hybrid materials
Methods for integrating the production of cellulose nanofibrils with the production of cellulose nanocrystals
Photoelectric conversion apparatus
  Randomly Featured Patents
Capacity changer
Homogenizing optical sheet, method of manufacture, and illumination system
Blade-equipped drilling tool, incorporating secondary cutting edges and passages designed for the removal of evacuated material
System for determining the true electrical characteristics of a device
Optical disc
Method of depositing perfume and compositions therefor
Neutral polysaccharide wall coating for electrophoretic separations in capillaries and microchannels
Fluid sample collection and introduction device
Stable coil designs
Hosta plant named `Purple Heart`